MarketCap
Facebook
X
Telegram
Acadia Healthcare Company Balance Sheet 2025-2008 | ACHC
Brief overview of Acadia Healthcare Company's balance sheet structure
The comparison uses five available annual reports from the 2021–2025 interval.
Over the period, assets gained +15.9%, moving from $4.8 billion to $5.5 billion. CAGR near 3.8% shows consistent growth.
Asset growth of +15.9% came with a +55% rise in liabilities. Financial leverage became more prominent.
The equity ratio is 35.3% versus 52.8% five periods ago. Capitalization remains workable.
Net debt equals about 1.21x of equity. The burden is manageable, but further growth would warrant attention.
The cash share moved from 2.8% to 2.4%. A higher figure generally provides more room in an adverse scenario.
The balance sheet includes a negative accumulated result of -$765.8 million. It should be assessed alongside historical profits and capital distributions.
Overall assessment
Acadia Healthcare Company's balance sheet profile remains vulnerable. Lower liabilities and capital accumulation are the main routes to improvement.
Annual Balance Sheet Acadia Healthcare Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
2.36 B | 1.83 B | 1.27 B | 1.29 B | 1.37 B | 2.61 B | 3.02 B | 3.14 B | 3.17 B | 3.23 B | 2.23 B | 1 B | 613 M | 424 M | 216 M | - | - | - |
Long Term Debt |
2.47 B | 1.88 B | 1.34 B | 1.36 B | 1.48 B | 2.97 B | 3.11 B | 3.16 B | 3.21 B | 3.25 B | 2.2 B | 1.07 B | 602 M | 466 M | 271 M | - | - | - |
Long Term Debt Current |
21.2 M | 25.5 M | 26.3 M | 26.5 M | 23.3 M | 18.9 M | 29.1 M | 34.1 M | 34.8 M | 34.8 M | 45.4 M | 27 M | 15.2 M | 7.68 M | 6.75 M | 9.98 M | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | 3.91 B | 3.42 B | 3.47 B | 3.51 B | 2.31 B | 1.18 B | 629 M | 479 M | 276 M | - | - | - |
Total Current Liabilities |
525 M | 578 M | 886 M | 388 M | 405 M | 1.31 B | 464 M | 416 M | 377 M | 343 M | 290 M | 166 M | 115 M | 71.9 M | 40.7 M | 18.1 M | - | - |
Total Liabilities |
3.39 B | 2.77 B | 2.47 B | 2.09 B | 2.19 B | 4.6 B | 4.34 B | 3.81 B | 3.83 B | 3.84 B | 2.59 B | 1.34 B | 744 M | 551 M | 317 M | 20.3 M | - | - |
Deferred Revenue |
2.8 M | 1.69 M | 2.16 M | 6.65 M | 30.4 M | 35.9 M | 38.5 M | 32.2 M | 31.3 M | 28.8 M | - | - | - | - | - | - | - | - |
Retained Earnings |
-766 M | 387 M | 132 M | 153 M | -120 M | -310 M | 362 M | 253 M | 429 M | 220 M | 214 M | 101 M | 18.4 M | -24.2 M | -44.6 M | - | - | - |
Total Assets |
5.53 B | 5.96 B | 5.36 B | 4.99 B | 4.77 B | 6.5 B | 6.88 B | 6.17 B | 6.42 B | 6.02 B | 4.28 B | 2.22 B | 1.22 B | 983 M | 413 M | 45.4 M | - | - |
Cash and Cash Equivalents |
133 M | 76.3 M | 100 M | 97.6 M | 134 M | 379 M | 124 M | 50.5 M | 67.3 M | 57.1 M | 11.2 M | 94 M | 4.57 M | 49.4 M | 61.1 M | 8.61 M | 4.49 M | 45 K |
Book Value |
2.14 B | 3.19 B | 2.89 B | 2.9 B | 2.58 B | 1.9 B | 2.54 B | 2.36 B | 2.6 B | 2.19 B | 1.69 B | 881 M | 481 M | 433 M | 96.4 M | 25.1 M | - | - |
Total Shareholders Equity |
1.95 B | 3.07 B | 2.78 B | 2.81 B | 2.52 B | 1.9 B | 2.51 B | 2.33 B | 2.57 B | 2.17 B | 1.68 B | 881 M | 481 M | 433 M | 96.4 M | 25.1 M | 21.2 M | 15.8 M |
All numbers in USD currency
Quarterly Balance Sheet Acadia Healthcare Company
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
2.49 B | 2.28 B | 2.25 B | 2.18 B | 1.88 B | 1.8 B | 1.77 B | 1.79 B | 1.34 B | 1.35 B | 1.37 B | 1.4 B | 1.36 B | 1.38 B | - | 1.46 B | 1.48 B | 1.41 B | 1.44 B | 1.48 B | 2.97 B | 2.97 B | 2.97 B | 2.97 B | 3.11 B | 3.11 B | 3.11 B | 3.11 B | 3.16 B | 3.16 B | 3.16 B | 3.16 B | 3.21 B | 3.21 B | 3.21 B | 3.21 B | 3.25 B | 3.25 B | 3.25 B | 3.25 B | 2.2 B | 2.2 B | 2.2 B | 2.2 B | 1.05 B | 1.07 B | 1.07 B | 1.07 B | 602 M | 602 M | 602 M | 602 M | 466 M | 466 M | 466 M | 466 M | 271 M | 271 M | 271 M | 271 M |
Total Liabilities |
3.38 B | 3.12 B | 3.08 B | 2.97 B | 2.77 B | 2.72 B | 2.61 B | 2.54 B | 2.47 B | 2.54 B | 2.14 B | 2.11 B | 2.09 B | 2.11 B | - | 2.19 B | 2.19 B | 2.1 B | 2.15 B | 2.17 B | 4.54 B | 4.54 B | 4.54 B | 4.54 B | 4.34 B | 4.34 B | 4.34 B | 4.34 B | 3.81 B | 3.81 B | 3.81 B | 3.81 B | 3.83 B | 3.83 B | 3.83 B | 3.83 B | 3.84 B | 3.84 B | 3.84 B | 3.84 B | 2.59 B | 2.59 B | 2.59 B | 2.59 B | 1.33 B | 1.34 B | 1.34 B | 1.34 B | 744 M | 744 M | 744 M | 744 M | 551 M | 551 M | 551 M | 551 M | 317 M | 317 M | 317 M | 317 M |
Deferred Revenue |
3.24 M | 3.26 M | 1.69 M | 1.81 M | 1.69 M | 1.69 M | 1.8 M | 2.15 M | 2.16 M | 2.58 M | 4.05 M | 5.1 M | 6.65 M | 9.49 M | - | 26.3 M | 30.4 M | 32.9 M | 41.3 M | 49.2 M | 35.9 M | 55.5 M | 35.9 M | 35.9 M | 1.9 M | 38.5 M | 38.5 M | 38.5 M | 32.2 M | 32.2 M | 32.2 M | 32.2 M | 31.3 M | 31.3 M | 31.3 M | 31.3 M | 28.8 M | 28.8 M | 28.8 M | 28.8 M | 446 K | 446 K | 446 K | 446 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-762 M | 412 M | 375 M | 348 M | 387 M | 355 M | 287 M | 208 M | 132 M | 74 M | 292 M | 219 M | 153 M | 92.3 M | - | -58.9 M | -120 M | -190 M | -256 M | -301 M | -310 M | -310 M | -310 M | -310 M | 362 M | 362 M | 362 M | 362 M | 253 M | 253 M | 253 M | 253 M | 429 M | 429 M | 429 M | 429 M | 220 M | 220 M | 220 M | 220 M | 214 M | 214 M | 214 M | 214 M | 101 M | 101 M | 101 M | 101 M | 18.4 M | 18.4 M | 18.4 M | 18.4 M | -24.2 M | -24.2 M | -24.2 M | -24.2 M | -44.6 M | -44.6 M | -44.6 M | -44.6 M |
Total Assets |
5.55 B | 6.41 B | 6.31 B | 6.15 B | 5.96 B | 5.87 B | 5.68 B | 5.52 B | 5.36 B | 5.35 B | 5.15 B | 5.04 B | 4.99 B | 4.94 B | - | 4.83 B | 4.77 B | 4.59 B | 4.56 B | 4.53 B | 6.5 B | 6.5 B | 6.5 B | 6.5 B | 6.88 B | 6.88 B | 6.88 B | 6.88 B | 6.17 B | 6.17 B | 6.17 B | 6.17 B | 6.42 B | 6.42 B | 6.42 B | 6.42 B | 6.02 B | 6.02 B | 6.02 B | 6.02 B | 4.28 B | 4.28 B | 4.28 B | 4.28 B | 2.21 B | 2.22 B | 2.22 B | 2.22 B | 1.22 B | 1.22 B | 1.22 B | 1.22 B | 983 M | 983 M | 983 M | 983 M | 413 M | 413 M | 413 M | 413 M |
Cash and Cash Equivalents |
158 M | 119 M | 131 M | 91.2 M | 76.3 M | 82.1 M | 77.2 M | 77.3 M | 100 M | 99.6 M | 112 M | 63.8 M | 97.6 M | 93.4 M | - | 140 M | 134 M | 196 M | 186 M | 179 M | 379 M | 379 M | 379 M | 379 M | 99.5 M | 124 M | 124 M | 124 M | 50.5 M | 50.5 M | 50.5 M | 50.5 M | 67.3 M | 67.3 M | 67.3 M | 67.3 M | 57.1 M | 57.1 M | 57.1 M | 57.1 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M | 94 M | 94 M | 94 M | 94 M | 4.57 M | 4.57 M | 4.57 M | 4.57 M | 49.4 M | 49.4 M | 49.4 M | 49.4 M | 61.1 M | 61.1 M | 61.1 M | 61.1 M |
Book Value |
2.17 B | 3.29 B | 3.22 B | 3.17 B | 3.19 B | 3.15 B | 3.06 B | 2.98 B | 2.89 B | 2.81 B | 3.01 B | 2.93 B | 2.9 B | 2.83 B | - | 2.64 B | 2.58 B | 2.5 B | 2.41 B | 2.35 B | 1.95 B | 1.95 B | 1.95 B | 1.95 B | 2.54 B | 2.54 B | 2.54 B | 2.54 B | 2.36 B | 2.36 B | 2.36 B | 2.36 B | 2.6 B | 2.6 B | 2.6 B | 2.6 B | 2.19 B | 2.19 B | 2.19 B | 2.19 B | 1.69 B | 1.69 B | 1.69 B | 1.69 B | 881 M | 881 M | 881 M | 881 M | 481 M | 481 M | 481 M | 481 M | 433 M | 433 M | 433 M | 433 M | 96.4 M | 96.4 M | 96.4 M | 96.4 M |
Total Shareholders Equity |
1.96 B | 3.12 B | 3.08 B | 3.04 B | 3.07 B | 3.03 B | 2.95 B | 2.87 B | 2.78 B | 2.71 B | 2.92 B | 2.84 B | 2.81 B | 2.74 B | 2.66 B | 2.57 B | 2.52 B | 2.43 B | 2.36 B | 2.3 B | 1.9 B | 1.9 B | 1.9 B | 1.9 B | 2.51 B | 2.51 B | 2.51 B | 2.51 B | 2.33 B | 2.33 B | 2.33 B | 2.33 B | 2.57 B | 2.57 B | 2.57 B | 2.57 B | 2.17 B | 2.17 B | 2.17 B | 2.17 B | 1.68 B | 1.68 B | 1.68 B | 1.68 B | 881 M | 881 M | 881 M | 881 M | 481 M | 481 M | 481 M | 481 M | 433 M | 433 M | 433 M | 433 M | 96.4 M | 96.4 M | 96.4 M | 96.4 M |
All numbers in USD currency
Balance Sheet is a fundamental financial report of Acadia Healthcare Company, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
China
USA
Russia
Germany
Britain
